Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 3, 2009, Pages 131-146

  Strong, Michael J ^a   Grace, Gloria M ^a,b   Freedman, Morris ^c   Lomen Hoerth, Cathy ^d   Woolley, Susan ^e   Goldstein, Laura ^f   Murphy, Jennifer ^d   Shoesmith, Christen ^a   Rosenfeld, Jeffery ^d   Leigh, P Nigel ^f   Bruijn, Lucie ^g   Ince, Paul ^h   Figlewicz, Denise ⁱ  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Forbes Norris MDA/ALS Research Center   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g ALS Association   (United States)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ Alzheimer Society of Canada   (Canada)

Author keywords

Dementia; Genetics; Neuropathology

Indexed keywords

ABNORMAL BEHAVIOR; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MOTOR NEURON DISEASE; MUTATION; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY; CONSENSUS; DEMENTIA; DISEASE COURSE; MENTAL DISEASE; PATHOLOGY; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; COGNITION DISORDERS; CONSENSUS; DEMENTIA; DISEASE PROGRESSION; HUMANS; MENTAL DISORDERS;

EID: 67651160559     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802654364     Document Type: Article

References (145)

1. Strong MJ. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:323-38.
2. Hodges JR, Miller B. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part 1. Neurocase. 2001;7:31-5.
3. Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, et al. Diagnostic criteria for the behavioural variant of frontotemporal dementia (bvFTD): Current limitations and future directions. Alzheimer Dis Assoc Disord. 2007;21:S14-8.
4. Lomen-Hoerth C, Strong MJ. Cognition in amyotrophic lateral sclerosis. In: Mitsumoto H, Przedborksi S, Gordon P, de Bene M, editors. Amyotrophic Lateral Sclerosis. London: Marcel Dekker, 2006. p. 115-38.
5. Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, et al. Frontotemporal dementia progresses to death faster than Alzheimer's disease. Neurology. 2005;65:719-25.
6. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, de Carli C, Jagust WJ, et al. Rate of progression differs in frontotemporal dementia and Alzheimer's disease. Neurology. 2005;65:397-403.
7. Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioural dysfunction on the course of ALS. Neurology. 2005;65:1774-7.
8. Poloni M, Capitani E, Mazzini L, Ceroni M. Neuropsychological measures in amyotrophic lateral sclerosis and their relationship with CT scan-assessed cerebral atrophy. Acta Neurol Scand. 1986;74:257-60.
9. Frank B, Haas J, Heinze HJ, Stark E, Munte TF. Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: Evidence for subgroups. Clin Neurol Neurosurg. 1997;99:79-86.
10. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586-90.
11. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094-7.
12. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130-3.
13. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive taunegative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Comm. 2006;351:602-11.
14. Kwong LK, Neumann M, Sampathu DM, Lee VMY, Trojanowski JQ. TDP-43 proteinopathy: The neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 2007;114:63-70.
15. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, et al. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol. 2007;66:152-7.
16. Wilson CM, Grace GM, Munoz DG, He BP, Strong MJ. Cognitive impairment in sporadic ALS. A pathological continuum underlying a multisystem disorder. Neurology. 2001;57:651-7.
17. Yang W, Sopper MM, Leystra-Lantz C, Strong MJ. Microtubule- associated tau protein positive neuronal and glial inclusions in amyotrophic lateral sclerosis. Neurology. 2003;61:1766-73.
18. Yoshida M. Amyotrophic lateral sclerosis with dementia: The clinicopathological spectrum. Neuropathology. 2004;24: 87-102.
19. Jackson M, Lennox G, Lowe J. Motor neuron diseaseinclusion dementia. Neurodegeneration. 1996;5:339-50.
20. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol. 2001;102:94-100.
21. Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530-4.
22. Guedj E, Le Ber I, Lacomblez I, Dubois B, Verpillat P, Didic M, et al. Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology. 2007;69:488-90.
23. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077-9.
24. World Federation of Neurology Research Group on Neuromuscular Disease. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124 (Suppl):96-107.
25. Brooks BR Miller RG Swash M Munsat TL for the World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
26. Chaudhari KR, Crump S, Al-Sarraj S, Anderson V, Cavanagh J, Leigh PN. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: A clinicopathological study. J Neurol Sci. 1995;129:11-2.
27. Ross MA, Miller RG, Berchert L, Parry GJ, Barohn RJ, Armon C, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis. Neurology. 1998;50:768-72.
28. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology.
29. Wheaton MW, Salamone AR, Mosnik DM, McDonald RO, Appel SH, Schmolck HI, et al. Cognitive impairment in familial ALS. Neurology. 2007;69:1411-7.
30. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/ Zn superoxide dismutase: Molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol. 1998;57:895-904.
31. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
32. Masè G, Ros S, Gemma A, Bonfigli L, Carraro N, Cazzato G, et al. ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci. 2001;191:11-8.
33. Battistini S, Giannini F, Greco G, Bibbò G, Ferrera L, Marini V, et al. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicentre Italian study. J Neurol. 2005;252:782-8.
34. Wicks P Abrahams S Papps B Al-Chalabi A Shaw C Leigh PN et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2008; in press.
35. Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J, et al. Familial non-specific dementia maps to chromosome 3. Hum Mol Genet. 1995;4:1625-8.
36. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, et al. ALS phenotypes with mutations in CHMP2B (charges multivesicular body protein 2B). Neurology. 2006;67:1074-7.
37. Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, et al. CHMPB2 mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett. 2006;398:83-4.
38. Blair IP Vance C Durnall JC Williams KL Thoeng A Shaw CE et al. CHMPB2 mutations are not a common cause of familial or sporadic ALS. J Neurol Neurosurg Psychiat. 2007;doi: 10.1136/jnnp/2007.140541.
39. Gellera C, Colobrita C, Ticozzi N, Castellotti B, Bragato C, Ratti A, et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics. 2008;9:33-40.
40. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5″-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702-5.
41. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-Parkinsonism- amyotrophy complex. Neurology. 1994;44:1878-84.
42. Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, et al. 17q-linked frontotemporal dementiaamyotrophic lateral sclerosis without tau mutations with tau and (-synuclein inclusions. Arch Neurol. 2004;61:398-406.
43. Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atarés B, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology. 2005;64:1578-85.
44. Kumar-Singh S, van Broeckhoven C. Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol. 2007;17:104-13.
45. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, et al. Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain. 2008;131:746.
46. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AMT, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: Comparison with patients with MAPT and no known mutations. Brain. 2008;131:721-31.
47. López de Munain A, Alzualde A, Gorostidi A, Otaegui D, Ruiz-Martinez J, Indakoetxea B, et al. Mutations in progranulin gene: Clinical, pathological, and ribonucleic acid expression findings. Biol Psychiatry. 2008;63:946-52.
48. Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis- frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiat. 2007;78:754-6.
49. Spina S, Murrell JR, Huey ED,Wassermann EM, Pietrini P, Baraibar MA, et al. Clinicopathological features of frontotemporal dementia with progranulin sequence variation. Neurology. 2007;68:820-7.
50. Hamilton RL, Bowser R. Alzheimer's disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol. 2004;107:515-22.
51. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-54.
52. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol. 2001;58:1803-9.
53. Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:67-74.
54. Gregory CA, Serra-Mestres J, Hodges JR. Early dementia of the frontal variant of frontotemporal dementia: How sensitive are standard neuroimaging and neuropsychological tests? Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:128-35.
55. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute for Neurological Disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-41.
56. Woolley-Levine S, Moore D, Katz J. What is the best verbal bedside tool to screen for cognitive impairment in ALS? Amyotroph Lateral Scler. 2007;8:101.
57. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734-47.
58. Yeudall LT, Fromm D, Reddon JR, Stefanyk WO. Normative data stratified by age and sex for 12 neuropsychological tests. J Clin Psychol. 1986;42:918-46.
59. Crawford JR, Moore JW, Cameron IM. A NART-based equation for the estimation of premorbid perfomance. Br J Clin Psychol. 1992;31:327-9.
60. Flaherty-Craig C, Eslinger P, Stephens B, Simmons Z. A rapid screening battery to identify frontal dysfunction in patients with ALS. Neurology. 2006;67:2070-2.
61. Woolley-Levine S, York M, Haring K, Lee C, Goodson W, Struut A, et al. Development of a cognitive behavioural screen for use with ALS patients: preliminary data. Amyotroph Lateral Scler. 2007;8:102.
62. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078-85.
63. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9.
64. Kertesz A, Davidson W, Fox H. Frontal behavioural inventory: Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29-36.
65. Blair M, Kertesz A, Davis-Faroque N, Hsiung GY, Black SE, Bouchard RW, et al. Behavioural measures in frontotemporal lobar dementia and other dementias: The utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study. Dement Geriatr Cogn Disord. 2008;23:406-15.
66. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi SA, Gornbein J. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-14.
67. Paulsen JS, Stout JC, de la Pena J, Romero R, Twafik-Reddy Z, Swenson MR, et al. Frontal-behavioural syndromes in cortical and subcortical dementia. Assessment. 1996;3:327-37.
68. Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioural changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56-61.
69. Benton AL, Hamsher KD, Sivan AB. Multilingual aphasia examination: manual of instructions, 3rd edn. Iowa City: AJA Associates, 1994.
70. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function system technical manual. San Antonio, TX: The Psychological Corporation, 2001.
71. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-65.
72. Heaton R, Chelune GJ, Talley J, Kay GG, Curtiss G. Wisconsin Card Sorting Test (WCST) manual: Revised and expanded. Odessa, Fl.: Psychological Assessment Resources, 1993.
73. Delis DC, Squire LR, Bihrle A, Massman P. Componential analysis of problem-solving ability: Performance of patients with frontal lobe damage and amnesic patients on a new sorting test. Neuropsychologia. 1992;30:697.
74. Jensen AR, Rohwer WD Jr. The Stroop colour-word test: A review. Acta Psychologica. 1966;25:36-93.
75. Corrigan JD, Hinkeldey MS. Relationships between parts A and B of the Trail Making Test. J Clinic Psychol. 1987;43:402-9.
76. Rey A. Psycological examination of traumatic encephalopathy. Archieves de Psychologic. 1941;28:286-340.
77. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test manual-adult version (second edition). New York: The Psychological Corporation, 2000.
78. Warrington EK. Recognition Memory Test. Windsor, UK: NFER-Nelson, 1984.
79. Sweet JJ, Demakis GJ, Ricker JH, Millis SR. Diagnostic efficiency and material specifictiy of the Warrington Recognition Memory Test. A collaborative multisite investigation. Arch Clin Neuropsychol. 2000;15:301-9.
80. Wechsler D. Wechsler Memory Scales-Third Edition (WMS-III). Administration and Scoring Manual. San Antonia, TX: The Psychological Corporation, 1997.
81. Kendrick DC, Gibson AJ, Moyes IC. The revised Kendrick battery: Clinical studies. Br J Soc Clin Psychol. 1979;18:329-40.
82. Lezak MD. Neuropsychological Assessment, 3rd edn. New York: New Oxford Press, 1995.
83. Peterson LR, Peterson MJ. Short-term retention of individual verbal items. Journal of Experimental Psychology. 1959;58:193-8.
84. Smith A. Symbol digit modalities test. Los Angeles, CA: Western Psychological Services, 1991.
85. Gronwall DMA. Paced auditory serial addition task: A measure of recovery from concussion. Percept Mot Skills. 1997;44:367-73.
86. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edn.. San Antonio, TX: The Psychological Corporation, 1997.
87. Goodglass H, Kaplan E. Boston Diagnostic Aphasia Examination - 2nd edn. Malvern, PA.: Lea & Febiger, 1983.
88. McKenna P, Warrington EK. The Graded Naming Test. Windsor: NFER-Nelson, 1983.
89. Howard D, Patterson K. Pyramid and Palm Trees. Bury St Edmunds, Suffolk: Thames Valley Test Company, 1992.
90. Dunn LM, Dunn ES. Peabody Picture Vocabulary Test-III. Circle Pinns: MN, 1997.
91. Dunn LM, Whetton C, Burley J. The British Picture Vocabulary Test. London, UK: GL Assessment, 1997.
92. Bishop D. Test for reception of grammar: Version 2 (TROG- 2). London, UK: Pearson Assessment, 2003.
93. Woodward JL, Benedict RHB, Roberts VJ, Goldstein FC, Kinner KM, Capruso DX, et al. Short-form alternatives to the Judgement of Lines Orientation test. J Clin Exp Psychol. 1996;18:898-904.
94. Benton AL, van Allen MW. Contribution to neuropsychological assessment. New York: Oxford University Press, 1983.
95. Colarusso RP, Hammill DD. Motor-Free Visual Perception Test - Revised. Novato, CA: Academic Therapy Publicaitons, 1996.
96. Warrington EK, James M. Visual Object and Space Perception Battery (VOSP). London, UK: Pearson Assessment, 1991.
97. Bright P, Jaldow E, Kopelman MD. The National Adult Reading Test as a measure of premorbid intelligence: A comparison with estimates derived from demographic variables. JINS. 2002;8:847-54.
98. Uttl B. North American Adult Reading Test: Age norms, reliability, and validity. J Clin Exp Neuropsych. 2002;24:1123-37.
99. Wechsler D. Wechsler Test of Adult Reading. San Antonio, TX: The Psychological Corporation, 2001.
100. Baddeley A, Emslie H, Nimmo-Smith I. Speed and Capacity of Language Processing. London, UK: Pearson, 1992.
101. Saxton JA, Ratcliff G, Dodge H, Pandav R, Baddeley A, Ganguli M. Speed and capacity of language processing test: Normative data from an older American community-dwelling sample. Appl Neuropsychol. 2001;8:193-203.
102. Beardsall L, Huppert F. Short NART, CCRTand Spot-the- Word: Comparisons in older and demented persons. Br J Clin Psychol. 1997;36:619-22.
103. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: The Psychological Corporation, 1999.
104. Axelrod BN. Validity of the Wechsler Abbreviated Scale of Intelligence and other very short forms of estimating intellectual function. Assessment. 2002;9:17-23.
105. Brink TL, Yesavage JA, Lum O, Heersema P, Adey MB, Rose TL. Screening tests for geriatric depression. Clinical Gerontologist. 1982;1:37-44.
106. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
107. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.
108. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, Texas: Psychological Corporation, 1996.
109. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67:361-70.
110. Nyenhuis DL, Luchetta T, Ymamoto C, Terrien A, Bernardin L, Rao SM, et al. The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory. J Pers Assess. 1998;70:386-401.
111. Wicks P, Abrahams S, Masi F, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993-1001.
112. Strong MJ, Gordon PH. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis - discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:8-16.
113. Strong MJ. The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther. 2003;98:379-414.
114. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: A statistical analysis of the world literature. Can J Neurol Sci. 1991;18:45-58.
115. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993;16:27-32.
116. Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve. 1989;12: 833-41.
117. Worms PM. The epidemiology of motor neuron diseases: A review of recent studies. J Neurol Sci. 2001;191:3-9.
118. Cashman NR Cudkowicz ME Davidson MC Pioro EP Rosenfeld J and the ALS Patient Care Database.. Gender effects on duration and onset age of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:41-2.
119. Nelson LM, Matkin C, Longstreth WT Jr, McGuire V. Population-based case control study of amyotrophic lateral sclerosis in western Washington State II Diet Am J Epidemiol. 2000;151:164-73.
120. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington state. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151: 156-63.
121. Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, et al. Neuropathological, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol. 2005;64:420-8.
122. Josephs KA, Holton JL, Rossort MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol. 2004;30:369-73.
123. Migheli A, Pezzulo T, Attanasio A, Schiffer D. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab Invest. 1993;68:185-91.
124. Wong N, He BP, Strong MJ. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol. 2000;59:972-82.
125. Strong MJ. Neurofilament metabolism in sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:170-7.
126. Leigh PN, Dodson A, Swash M, Brion J-P, Anderton BH. Cytoskeletal abnormalities in motor neuron disease. An immunohistochemical study. Brain. 1989;112:521-35.
127. van Welsem ME, Hogenhuis JA, Meininger V, Metsaars WP, Hauw JJ, Seilhean D. The relationship between Bunina bodies, skein-like inclusions and neuronal loss in amyotrophic lateral sclerosis. Acta Neuropathol. 2002;103: 583-9.
128. Wharton S, Ince PG. Pathology of motor neuron disorders. In: Shaw PJ, Strong MJ, editors. Motor Neuron Disorders. 1st edn. Philadelphia: Butterworth Heinemann, 2003. p. 17-50.
129. Noda K, Katayama S, Watanabe C, Yamamura Y, Nakamura S. Gallyas- and tau-positive glial structures in motor neuron disease with dementia. Clin Neuropath. 1999;18: 218-25.
130. Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, et al. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol. 2001;58: 1813-6.
131. Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, Okazaki E, et al. Rapidly progressing aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200-7.
132. Ferrer I, Roig C, Espino A, Peiro G, Matias Guiu X. Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiat. 1991;54:932-4.
133. Kato S, Oda M, Hayashi H, Kawata A, Shimizu T. Participation of the limbic system and its associated areas in the dementia of amyotrophic lateral sclerosis. J Neurol Sci. 1994;126:62-9.
134. Kawashima T, Kikuchi H, Takita M, Doh-ura K, Ogomori K, Oda M, et al. Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia. Acta Neuropathol. 1998;96:541-5.
135. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiat. 1984;47:953-9.
136. Munoz DG. The pathology of Pick complex. In: Kertesz A, Munoz DG, editors. Pick's disease and Pick complex. New York: John Wiley and Sons, 1998. p. 211-39.
137. Horoupian DS, Katzman R, Terry RD, Davies P, Hirano A, de Tersa R, et al. Dementia and motor neuron disease: Morphometric, biochemical and Golgi studies. Ann Neurol. 1984;16:305-13.
138. Brun A, Passant U. Frontal lobe degeneration of non- Alzheimer type. Acta Neurol Scand. 1996;168:28-30.
139. Giannakopoulos P, Hof PR, Bouras C. Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases. Acta Neuropathol (Berl). 1995;89:346-55.
140. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol. 1996;91: 127-34.
141. Soni W, Luthert PJ, Leigh PN, Mann DMA. A morphometric study of the neuropathological substrate of dementia in patients with motor neuron disease. Neuropathol Appl Neurobiol. 1993;19:203.
142. Nishikawa Y, Tan C-F, Onodera O, Toyoshima Y, Yamada M, Morita T, et al. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169-82.
143. Dickson DW, Josephs KA, Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 2008;114:71-9.
144. Mori F, Tanji K, Zhang H-X, Nishihira Y, Tan C-F, Takahashi H, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;116:193-203.
145. Mackenzie IRA. The neuropathology of FTD associated with ALS. Alzheimer Dis Assoc Disord. 2008;21:S44-9